Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma
This study has been completed.
Sponsor:
Idera Pharmaceuticals, Inc.
Information provided by:
Idera Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00729053
First received: August 1, 2008
Last updated: January 8, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2008 |
| Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |